Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bacterial Infections and Mycoses

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 112 articles:
HTML format
Text format



Single Articles


    October 2018
  1. CAMPBELL AJ, Dotel R, Blyth CC, Davis JS, et al
    Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal.
    J Antimicrob Chemother. 2018 Oct 10. pii: 5126432. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. DOAN TN, Fox GJ, Meehan MT, Scott N, et al
    Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
    J Antimicrob Chemother. 2018 Oct 5. pii: 5116208. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. TYSON GH, Sabo JL, Hoffmann M, Hsu CH, et al
    Novel linezolid resistance plasmids in Enterococcus from food animals in the USA.
    J Antimicrob Chemother. 2018 Oct 1. pii: 5106682. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  4. XHEMALI X, Smith JR, Kebriaei R, Rice SA, et al
    Evaluation of dalbavancin alone and in combination with beta-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Sep 27. pii: 5107805. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. AUTMIZGUINE J, Smith PB, Prather K, Bendel C, et al
    Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.
    J Antimicrob Chemother. 2018 Sep 20. pii: 5104445. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. ZHOU X, Chlebowicz MA, Bathoorn E, Rosema S, et al
    Elucidating vancomycin-resistant Enterococcus faecium outbreaks: the role of clonal spread and movement of mobile genetic elements.
    J Antimicrob Chemother. 2018 Sep 14. pii: 5096847. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. CHANNABASAPPA S, Chikkamadaiah R, Durgaiah M, Kumar S, et al
    Efficacy of chimeric ectolysin P128 in drug-resistant Staphylococcus aureus bacteraemia in mice.
    J Antimicrob Chemother. 2018 Sep 11. pii: 5095203. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. LEE RS, Goncalves da Silva A, Baines SL, Strachan J, et al
    The changing landscape of vancomycin-resistant Enterococcus faecium in Australia: a population-level genomic study.
    J Antimicrob Chemother. 2018 Sep 4. pii: 5090546. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  9. PASQUAROLI S, Citterio B, Mangiaterra G, Biavasco F, et al
    Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.
    J Antimicrob Chemother. 2018 Aug 29. pii: 5086495. doi: 10.1093.
    PubMed     Text format    


  10. CAMARA J, Cubero M, Martin-Galiano AJ, Garcia E, et al
    Evolution of the beta-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5079858. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. MACFADYEN AC, Harrison EM, Ellington MJ, Parkhill J, et al
    A highly conserved mecC-encoding SCCmec type XI in a bovine isolate of methicillin-resistant Staphylococcus xylosus.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5084893. doi: 10.1093.
    PubMed     Text format    


  12. RIGAILL J, Morgene MF, Gavid M, Lelonge Y, et al
    Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization.
    J Antimicrob Chemother. 2018 Aug 16. pii: 5075188. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. DEPLANO A, Dodemont M, Denis O, Westh H, et al
    European external quality assessments for identification, molecular typing and characterization of Staphylococcus aureus.
    J Antimicrob Chemother. 2018 Aug 7. pii: 5067736. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. HANSEN TA, Pedersen MS, Nielsen LG, Ma CMG, et al
    Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX.
    J Antimicrob Chemother. 2018 Aug 2. pii: 5064278. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. BERKOW EL, Lockhart SR
    Activity of novel antifungal compound APX001A against a large collection of Candida auris.
    J Antimicrob Chemother. 2018 Aug 1. pii: 5063540. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  16. WIEDERHOLD NP, Locke JB, Daruwala P, Bartizal K, et al
    Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
    J Antimicrob Chemother. 2018 Jul 18. pii: 5055842. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. ROGIERS O, Holtappels M, Siala W, Lamkanfi M, et al
    Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.
    J Antimicrob Chemother. 2018 Jul 13. pii: 5053967. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. WHITFIELD MG, Warren RM, Mathys V, Scott L, et al
    The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Jul 5. pii: 5049577. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  20. ADAM HJ, Golden AR, Karlowsky JA, Baxter MR, et al
    Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  21. ZHANEL GG, Adam HJ
    Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  22. KARLOWSKY JA, Adam HJ, Golden AR, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


    June 2018
  23. GARVEY EP, Sharp AD, Warn PA, Yates CM, et al
    The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.
    J Antimicrob Chemother. 2018 Jun 26. pii: 5045560. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. TAVERNIER S, Sass A, De Bruyne M, Baeke F, et al
    Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036452. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. BOUDJEMAA R, Steenkeste K, Jacqueline C, Briandet R, et al
    Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036450. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. DESHPANDE LM, Castanheira M, Flamm RK, Mendes RE, et al
    Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    J Antimicrob Chemother. 2018 Jun 6. pii: 5033815. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  27. TALBOT JJ, Subedi S, Halliday CL, Hibbs DE, et al
    Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    J Antimicrob Chemother. 2018 May 29. pii: 5018389. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 May 25. pii: 5003466. doi: 10.1093.
    PubMed     Text format    


  29. BREAK TJ, Desai JV, Healey KR, Natarajan M, et al
    VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
    J Antimicrob Chemother. 2018 May 16. pii: 4996888. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  30. SEUFERT R, Sedlacek L, Kahl B, Hogardt M, et al
    Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4978322. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. HAGER CL, Larkin EL, Long LA, Ghannoum MA, et al
    Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model.
    J Antimicrob Chemother. 2018 Apr 19. pii: 4979534. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. RIZZATO C, Poma N, Zoppo M, Posteraro B, et al
    CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates.
    J Antimicrob Chemother. 2018 Apr 9. pii: 4964989. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2018 Apr 5. pii: 4962127. doi: 10.1093.
    PubMed     Text format    


  34. HASHEMI MM, Rovig J, Holden BS, Taylor MF, et al
    Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960903. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  35. CANEZIN PH, Caleffi-Ferracioli KR, Scodro RBL, Siqueira VLD, et al
    Intramacrophage Mycobacterium tuberculosis efflux pump gene regulation after rifampicin and verapamil exposure.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951545. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. DALL GF, Tsang SJ, Gwynne PJ, MacKenzie SP, et al
    Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937886. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. CARTER GP, Harjani JR, Li L, Pitcher NP, et al
    1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    J Antimicrob Chemother. 2018 Mar 6. pii: 4922693. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  39. THIEME L, Klinger-Strobel M, Hartung A, Stein C, et al
    In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913717. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. MCCARTY TP, Lockhart SR, Moser SA, Whiddon J, et al
    Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes.
    J Antimicrob Chemother. 2018 Feb 28. pii: 4913721. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. RODRIGUEZ-CASTRO E, Trastoy R, Rodriguez-Osorio X, Dominguez-Santalla MJ, et al
    Meningitis due to autochthonous acute infection with hepatitis E virus in a chef: a case report.
    J Antimicrob Chemother. 2018 Feb 21. pii: 4898172. doi: 10.1093.
    PubMed     Text format    


  42. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. WESSELS C, Strommenger B, Klare I, Bender J, et al
    Emergence and control of linezolid-resistant Staphylococcus epidermidis in an ICU of a German hospital.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847818. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. KAMBAREV S, Pecorari F, Corvec S
    Novel Tn916-like elements confer aminoglycoside/macrolide co-resistance in clinical isolates of Streptococcus gallolyticus ssp. gallolyticus.
    J Antimicrob Chemother. 2018 Feb 9. pii: 4847819. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. SUN C, Zhang P, Ji X, Fan R, et al
    Presence and molecular characteristics of oxazolidinone resistance in staphylococci from household animals in rural China.
    J Antimicrob Chemother. 2018 Feb 7. pii: 4841776. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. HUH HJ, Song DJ, Shim HJ, Kwon WK, et al
    Performance evaluation of the QMAC-dRAST for staphylococci and enterococci isolated from blood culture: a comparative study of performance with the VITEK-2 system.
    J Antimicrob Chemother. 2018 Feb 3. pii: 4837262. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. NEVES FPG, Cardoso NT, Souza ARV, Snyder RE, et al
    Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.
    J Antimicrob Chemother. 2018 Feb 1. pii: 4833983. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  48. LESTRADE PP, van der Velden WJFM, Bouwman F, Stoop FJ, et al
    Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4831957. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. DOOKIE N, Rambaran S, Padayatchi N, Mahomed S, et al
    Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817621. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. LAYER F, Vourli S, Karavasilis V, Strommenger B, et al
    Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817623. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. CHOWDHARY A, Prakash A, Sharma C, Kordalewska M, et al
    A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4794718. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  54. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. EDSLEV SM, Clausen ML, Agner T, Stegger M, et al
    Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745837. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. LIU Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, et al
    Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
    J Antimicrob Chemother. 2017 Dec 12. pii: 4735127. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. CHEN C, Hooper DC
    Effect of Staphylococcus aureus Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess model.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693732. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. ZHANG P, Wright JA, Tymon A, Nair SP, et al
    Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants.
    J Antimicrob Chemother. 2017 Dec 4. pii: 4688916. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  59. PITT R, Alexander S, Ison C, Horner P, et al
    Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    J Antimicrob Chemother. 2017 Nov 30. pii: 4682922. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. KONTOYIANNIS DP, Selleslag D, Mullane K, Cornely OA, et al
    Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    J Antimicrob Chemother. 2017 Nov 29. pii: 4675068. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. WIEDERHOLD NP, Patterson HP, Tran BH, Yates CM, et al
    Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.
    J Antimicrob Chemother. 2017 Nov 27. pii: 4669681. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2017 Nov 21. pii: 4644442. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. FREITAS AR, Tedim AP, Novais C, Coque TM, et al
    Distribution of putative virulence markers in Enterococcus faecium: towards a safety profile review.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. COSTA SS, Viveiros M, Pomba C, Couto I, et al
    Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen.
    J Antimicrob Chemother. 2017 Nov 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. GODET C, Alastruey-Izquierdo A, Flick H, Hennequin C, et al
    A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention.
    J Antimicrob Chemother. 2017 Nov 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format    


    October 2017
  68. DORTET L, Glaser P, Kassis-Chikhani N, Girlich D, et al
    Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. VYAZOVAYA A, Levina K, Zhuravlev V, Viiklepp P, et al
    Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. FOSCHI C, Salvo M, Cevenini R, Marangoni A, et al
    Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
    J Antimicrob Chemother. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. CHEN CJ, Lauderdale TY, Lu CT, Chuang YY, et al
    Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. SEAS C, Garcia C, Salles MJ, Labarca J, et al
    Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
    J Antimicrob Chemother. 2017 Oct 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  74. BREAK TJ, Desai JV, Natarajan M, Ferre EMN, et al
    VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format    


  76. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. YEW WW, Liang D, Chan DP, Shi W, et al
    Molecular mechanisms of clofazimine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017;72:2943-2944.
    PubMed     Text format    


  78. SINGH R, Almutairi M, Alm RA, Lahiri SD, et al
    Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
    J Antimicrob Chemother. 2017;72:2796-2803.
    PubMed     Text format     Abstract available


  79. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Text format     Abstract available


  80. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Text format     Abstract available


  81. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Text format     Abstract available


  82. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Text format     Abstract available


    September 2017
  83. FREITAS AR, Elghaieb H, Leon-Sampedro R, Abbassi MS, et al
    Detection of optrA in the African continent (Tunisia) within a mosaic Enterococcus faecalis plasmid from urban wastewaters.
    J Antimicrob Chemother. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. CHEN J, Zhang S, Cui P, Shi W, et al
    Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. PASIPANODYA JG, Ogbonna D, Deshpande D, Srivastava S, et al
    Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  87. DESHPANDE D, Srivastava S, Gumbo T
    A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  88. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  89. DESHPANDE D, Srivastava S, Pasipanodya JG, Lee PS, et al
    Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  90. DESHPANDE D, Srivastava S, Pasipanodya JG, Gumbo T, et al
    Linezolid as treatment for pulmonary Mycobacterium avium disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  91. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


    August 2017
  92. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. GONZALEZ MORENO M, Trampuz A, Di Luca M
    Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis.
    J Antimicrob Chemother. 2017 Aug 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  95. SINGH AK, Thakare R, Karaulia P, Das S, et al
    Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  96. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. COJUTTI PG, Candoni A, Ramos-Martin V, Lazzarotto D, et al
    Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.
    J Antimicrob Chemother. 2017;72:2342-2350.
    PubMed     Text format     Abstract available


  99. CORNELY OA, Leguay T, Maertens J, Vehreschild MJGT, et al
    Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
    J Antimicrob Chemother. 2017;72:2359-2367.
    PubMed     Text format     Abstract available


  100. TAUBERT M, Zander J, Frechen S, Scharf C, et al
    Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.
    J Antimicrob Chemother. 2017;72:2304-2310.
    PubMed     Text format     Abstract available


  101. BEVAN ER, Jones AM, Hawkey PM
    Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype.
    J Antimicrob Chemother. 2017;72:2145-2155.
    PubMed     Text format     Abstract available


  102. AYDIN S, Personne Y, Newire E, Laverick R, et al
    Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli.
    J Antimicrob Chemother. 2017;72:2213-2218.
    PubMed     Text format     Abstract available


  103. MATSUMURA Y, Peirano G, Devinney R, Bradford PA, et al
    Genomic epidemiology of global VIM-producing Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2249-2258.
    PubMed     Text format     Abstract available


  104. SVENSSON RJ, Gillespie SH, Simonsson USH
    Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
    J Antimicrob Chemother. 2017;72:2311-2319.
    PubMed     Text format     Abstract available


  105. LIVERMORE DM, Mushtaq S, Meunier D, Hopkins KL, et al
    Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
    J Antimicrob Chemother. 2017;72:2278-2289.
    PubMed     Text format     Abstract available


  106. BOTELHO J, Grosso F, Quinteira S, Mabrouk A, et al
    The complete nucleotide sequence of an IncP-2 megaplasmid unveils a mosaic architecture comprising a putative novel blaVIM-2-harbouring transposon in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2017;72:2225-2229.
    PubMed     Text format     Abstract available


  107. LAGACE-WIENS PRS, Adam HJ, Laing NM, Baxter MR, et al
    Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.
    J Antimicrob Chemother. 2017;72:2273-2277.
    PubMed     Text format     Abstract available


  108. CHATTERJEE S, Mondal A, Mitra S, Basu S, et al
    Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.
    J Antimicrob Chemother. 2017;72:2201-2207.
    PubMed     Text format     Abstract available


  109. VARGAS-PALACIOS A, Meads DM, Twiddy M, Czoski Murray C, et al
    Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.
    J Antimicrob Chemother. 2017;72:2392-2400.
    PubMed     Text format     Abstract available


  110. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Text format     Abstract available


  111. DOUMITH M, Findlay J, Hirani H, Hopkins KL, et al
    Major role of pKpQIL-like plasmids in the early dissemination of KPC-type carbapenemases in the UK.
    J Antimicrob Chemother. 2017;72:2241-2248.
    PubMed     Text format     Abstract available


    July 2017
  112. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: